SCHEMBL3669451

SCHEMBL3669451

NCC(CN)OCc1ccc(COC(CN)CN)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.44
CHRNA4 P43681 1/20 0.44
IDO1 P14902 13/20 0.37
AGXT P21549 7/20 0.36
CYP3A4 P08684 2/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
ABAT P80404 1/20 0.35
SLC1A3 P43003 2/20 0.34
SLC1A2 P43004 2/20 0.34
SLC1A1 P43005 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17264302 0.88 IDO1 (0.50) CHRNB2CHRNA4IDO1AGXTCA2
SCHEMBL2557127 0.78 EPHX1 (0.45) CHRNB2CHRNA4IDO1AGXTSLC1A3
SCHEMBL11197240 0.77 SLC1A3 (0.46) CHRNB2CHRNA4IDO1AGXTCA2
SCHEMBL24566617 0.74 CHRNB2 (0.41) CHRNB2CHRNA4IDO1AGXTCA2
SCHEMBL9188228 0.74 IDO1 (0.36) CHRNB2CHRNA4IDO1AGXTCYP3A4
SCHEMBL14173592 0.72 SLC1A3 (0.42) CHRNB2CHRNA4IDO1AGXTCYP3A4
SCHEMBL22433619 0.70 IDO1 (0.46) CHRNB2CHRNA4IDO1AGXTCA2
SCHEMBL17227561 0.69 LOXL2 (0.43) CHRNB2CHRNA4IDO1CYP3A4
SCHEMBL4299693 0.69 IDO1 (0.50) CHRNB2CHRNA4IDO1AGXTCA2
SCHEMBL7174942 0.69 IDO1 (0.48) IDO1CA2ABATMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139461-A2 AMINO DERIVATIVES TO PREVENT NEPHROTOXICITY AND CANCER Recepticon Aps (DK) 2010-01-06 EP disclosed
WO-2008113364-A2 AMINO DERIVATIVES TO PREVENT NEPHROTOXICITY AND CANCER RECEPTICON APS (DK) 2008-09-25 WO disclosed